(Q54960633)

13 June 2018

editorial

0 references

title

Kinase inhibitors in clinical practice: An expanding world. (English)

1 reference

13 June 2018

phosphatidylinositol 3-kinases

main subject

0 references

author name string

Ruchi Pandey

series ordinal

1

1 reference

13 June 2018

Reuben Kapur

series ordinal

2

1 reference

13 June 2018

language of work or name

English

0 references

publication date

8 August 2017

1 reference

13 June 2018

The Journal of Allergy and Clinical Immunology

number of pages

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

13 June 2018

volume

141

1 reference

13 June 2018

issue

2

1 reference

13 June 2018

page(s)

522-524

1 reference

13 June 2018

The Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium tuberculosis Growth through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling.

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5848208

Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5848208

Dasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor Models

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5848208

PI3Kγ is a molecular switch that controls immune suppression

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5848208

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5848208

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5848208

Targeting neoplastic B cells and harnessing microenvironment: the "double face" of ibrutinib and idelalisib

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5848208

Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) Antivirals.

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5848208

Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5848208

10.1016/J.JACI.2017.07.016

13 August 2018

Identifiers

DOI

1 reference

13 June 2018

PMC publication ID

5848208

1 reference

13 June 2018

PubMed publication ID

28801197

1 reference

13 June 2018